Abu Dhabi Investment Authority → Eikon Therapeutics, Inc. (EIKN)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

15 filings by this filer

14 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 8.79

6,294,602 shares short · +15.4% vs prior

Other Filings by Abu Dhabi Investment Authority

Filed	Form	Issuer	Stake	Shares
2026-09-30	SCHEDULE 13D/A	AGL Private Credit Income Fund	75.10%	20,319,560.62	view →
2026-08-11	SCHEDULE 13D/A	ReNew Energy Global plc	23.64%	58,170,916	view →
2026-07-30	SCHEDULE 13D/A	Overland Advantage	55.90%	17,750,646.43	view →
2026-07-27	SCHEDULE 13D/A	Jefferies Credit Partners BDC Inc.	45.50%	26,794,407.97	view →
2026-05-20	SCHEDULE 13D/A	Senior Credit Investments, LLC	100.00%	146,633.63	view →
2025-10-10	SCHEDULE	ReNew Energy Global plc RNWWW	23.80%	58,170,916	view →
2025-09-26	SCHEDULE	AGL Private Credit Income Fund	89.00%	18,362,831	view →
2025-06-20	SCHEDULE	AGL Private Credit Income Fund	93.60%	13,801,429	view →
2025-03-07	SCHEDULE	Senior Credit Investments, LLC	100.00%	97,607	view →
2025-02-25	SCHEDULE	Senior Credit Investments, LLC	100.00%	93,472	view →
2025-02-11	SCHEDULE	Overland Advantage	60.70%	10,389,251	view →
2025-01-22	SCHEDULE	Jefferies Credit Partners BDC Inc.	70.00%	17,435,119	view →
2025-01-02	SCHEDULE	AGL Private Credit Income Fund	99.60%	8,727,114	view →
2023-03-15	SC	Alight, Inc. / Delaware ALIT	—	—	view →

Abu Dhabi Investment Authority → Eikon Therapeutics, Inc. EIKN

Item 4 — Purpose of Transaction

Cross-References

Other Filings by Abu Dhabi Investment Authority

Want this depth on every filing the moment it hits SEC EDGAR?